Point-of-Care CD4 Price Reduction

Published May 8th, 2015

In 2014, CHAI negotiated a 67 percent price reduction for service and maintenance for the first point-of-care (POC) CD4 product in the market (Pima), and has accelerated the market entry of a second supplier (BD FACS Presto), which will facilitate further price reductions for POC CD4 tests.